DIA Europe 2019 has ended
avatar for Adam Parnaby

Adam Parnaby

Celgene, France
Senior Director Market Access Policy, Worldwide Markets
Adam has 18 years of experience in the pharma industry and started his career as an academic health economist. Previously, he was Director of Pricing and Market Access for Celgene’s Oncology portfolio in the EMEA region. Prior to joining Celgene, he worked in Health Economics and Market Access roles at GSK, Pfizer and Sanofi. He is currently Vice-Chair of the EFPIA Health Technology Assessment Working Group and plays a significant role in the evolving HTA environment. He currently works on a range of topics including HTA Policy, Payer evidence development, Pricing Models to support patient access to innovative therapies. He is actively engaged in the debate around healthcare sustainability.